These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31079220)

  • 41. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein.
    Hwang J; Suh HW; Jeon YH; Hwang E; Nguyen LT; Yeom J; Lee SG; Lee C; Kim KJ; Kang BS; Jeong JO; Oh TK; Choi I; Lee JO; Kim MH
    Nat Commun; 2014; 5():2958. PubMed ID: 24389582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila.
    Cheng Z; Arscott LD; Ballou DP; Williams CH
    Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thioredoxin, thioredoxin reductase, and alpha-crystallin revive inactivated glyceraldehyde 3-phosphate dehydrogenase in human aged and cataract lens extracts.
    Yan H; Lou MF; Fernando MR; Harding JJ
    Mol Vis; 2006 Oct; 12():1153-9. PubMed ID: 17093401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential Anticancer Activity of Auranofin.
    Onodera T; Momose I; Kawada M
    Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue.
    Zhu X; Huang C; Peng B
    Oral Oncol; 2011 Jul; 47(7):609-14. PubMed ID: 21652258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular characterization of thioredoxin-1 and thioredoxin reductase activity in mud crab Scylla paramamosain.
    Hu JH; Zhang FY; Jiang KJ; Fang YB; Wang J; Zhao M; Qiao ZG; Ma LB
    Genet Mol Res; 2014 Dec; 13(4):10241-55. PubMed ID: 25501236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting the Thioredoxin Reductase-Thioredoxin System from Staphylococcus aureus by Silver Ions.
    Liao X; Yang F; Li H; So PK; Yao Z; Xia W; Sun H
    Inorg Chem; 2017 Dec; 56(24):14823-14830. PubMed ID: 29182243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer.
    Zhou J; Chng WJ
    Mitochondrion; 2013 May; 13(3):163-9. PubMed ID: 22750447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion.
    Nivet-Antoine V; Cottart CH; Lemaréchal H; Vamy M; Margaill I; Beaudeux JL; Bonnefont-Rousselot D; Borderie D
    Biochimie; 2010 Dec; 92(12):1766-71. PubMed ID: 20709139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
    Söderberg A; Sahaf B; Rosén A
    Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity.
    Ahrens TD; Timme S; Ostendorp J; Bogatyreva L; Hoeppner J; Hopt UT; Hauschke D; Werner M; Lassmann S
    Lab Invest; 2016 Mar; 96(3):307-16. PubMed ID: 26692290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system.
    Wipf P; Lynch SM; Birmingham A; Tamayo G; Jiménez A; Campos N; Powis G
    Org Biomol Chem; 2004 Jun; 2(11):1651-8. PubMed ID: 15162219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
    Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
    Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
    Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS
    Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
    Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
    Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-oxidative and Anti-apoptotic Effects of Acupuncture: Role of Thioredoxin-1 in the Hippocampus of Vascular Dementia Rats.
    Zhu W; Wang XR; Du SQ; Yan CQ; Yang NN; Lin LL; Shi GX; Liu CZ
    Neuroscience; 2018 May; 379():281-291. PubMed ID: 29592844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook.
    Pan M; Zhang F; Qu K; Liu C; Zhang J
    Oxid Med Cell Longev; 2022; 2022():7805115. PubMed ID: 35450411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Revival of glutathione reductase in human cataractous and clear lens extracts by thioredoxin and thioredoxin reductase, in conjunction with alpha-crystallin or thioltransferase.
    Yan H; Harding JJ; Xing K; Lou MF
    Curr Eye Res; 2007 May; 32(5):455-63. PubMed ID: 17514531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thioredoxin reductase inhibitors: a patent review.
    Zhang B; Zhang J; Peng S; Liu R; Li X; Hou Y; Han X; Fang J
    Expert Opin Ther Pat; 2017 May; 27(5):547-556. PubMed ID: 27977313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization and immune function of the thioredoxin-interacting protein (TXNIP) from Litopenaeus vannamei.
    Zuo H; Yuan J; Yang L; Liang Z; Weng S; He J; Xu X
    Fish Shellfish Immunol; 2019 Jan; 84():20-27. PubMed ID: 30261300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.